These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14750457)

  • 1. [Reports of transfusion incidents: experiences from the first year of hemovigilance in the region of the former ZWN (South West Netherlands) blood bank in Rotterdam].
    Deimann LG
    Ned Tijdschr Geneeskd; 2004 Jan; 148(1):50. PubMed ID: 14750457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reports of transfusion incidents: experiences from the first year of hemovigilance in the region of the former ZWN (South West Netherlands) blood bank in Rotterdam].
    Beckers EA; Dinkelaar RB; te Boekhorst PA; van Ingen HE; van Rhenen DJ
    Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1508-12. PubMed ID: 12924082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion reactions in patients: haemovigilance reports to the Dutch National Haemovigilance Office in 2003].
    Wiersum-Osselton JC; Schipperus MR
    Ned Tijdschr Geneeskd; 2005 Nov; 149(47):2622-7. PubMed ID: 16355575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Quebec hemovigilance system: description and results from the first two years.
    Robillard P; Nawej KI; Jochem K
    Transfus Apher Sci; 2004 Oct; 31(2):111-22. PubMed ID: 15501415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemovigilance: a joint responsibility of hospitals and blood banks].
    van Aken WG
    Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1490-2. PubMed ID: 12924077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemovigilance: concept, Europe and UK initiatives.
    McClelland B; Love E; Scott S; Williamson LM
    Vox Sang; 1998; 74 Suppl 2():431-9. PubMed ID: 9704478
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality assurance of blood components prepared in the blood transfusion center/blood bank.
    Vox Sang; 1994; 67(1):99-111. PubMed ID: 7975467
    [No Abstract]   [Full Text] [Related]  

  • 8. The French Haemovigilance System: organization and results for 2003.
    Rebibo D; Hauser L; Slimani A; Hervé P; Andreu G
    Transfus Apher Sci; 2004 Oct; 31(2):145-53. PubMed ID: 15501418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What is the use of hemovigilance?].
    Quaranta JF; Canivet N
    Transfus Clin Biol; 1998 Dec; 5(6):415-21. PubMed ID: 9894333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6 Years of shot reporting--its influence on UK blood safety.
    Stainsby D; Williamson L; Jones H; Cohen H
    Transfus Apher Sci; 2004 Oct; 31(2):123-31. PubMed ID: 15501416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consecutive national surveys of ABO-incompatible blood transfusion in Japan.
    Fujii Y; Shibata Y; Miyata S; Inaba S; Asai T; Hoshi Y; Takamatsu J; Takahashi K; Ohto H; Juji T; Sagawa K
    Vox Sang; 2009 Oct; 97(3):240-6. PubMed ID: 19476605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998.
    Andreu G; Morel P; Forestier F; Debeir J; Rebibo D; Janvier G; Hervé P
    Transfusion; 2002 Oct; 42(10):1356-64. PubMed ID: 12423521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemovigilance in the United States of America.
    Menitove JE
    Vox Sang; 1998; 74 Suppl 2():447-55. PubMed ID: 9704480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The French haemovigilance system.
    Noel L; Debeir J; Cosson A
    Vox Sang; 1998; 74 Suppl 2():441-5. PubMed ID: 9704479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Under pressure.
    Siddall R
    Health Serv J; 2003 Aug; 113(5869):12-3. PubMed ID: 12953390
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion medicine monitoring practices. A study of the College of American Pathologists/Centers for Disease Control and Prevention Outcomes Working Group.
    Boone DJ; Steindel SD; Herron R; Howanitz PJ; Bachner P; Meier F; Schifman RB; Zarbo RB
    Arch Pathol Lab Med; 1995 Nov; 119(11):999-1006. PubMed ID: 7487418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lead levels in blood bank blood.
    Bulleova S; Rothenberg SJ; Manalo MA
    Arch Environ Health; 2001; 56(4):312-3. PubMed ID: 11572273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis of the debates of the 2d National Congress of Transfusion Safety and Hemovigilance].
    Janvier G; Fialon P
    Transfus Clin Biol; 1998 Jun; 5(3):189-92. PubMed ID: 9691362
    [No Abstract]   [Full Text] [Related]  

  • 19. [Assessment of the implementation of the hemovigilance and transfusion safety system in French hospitals and blood transfusion centers].
    Fialon P; Quaranta JF; Lemonnier MP; Bricard H; Nublat M; Laxenaire MC; Blanloeil Y; Galperine I; Baron JF; Gross S; Fournel JJ; Vezon G; Janvier G
    Transfus Clin Biol; 1998 Jun; 5(3):193-202. PubMed ID: 9691363
    [No Abstract]   [Full Text] [Related]  

  • 20. [Accidental transfusion with ABO-incompatible blood: process for analysis of the contributing causes].
    Indrikovs AJ
    Sangre (Barc); 1997 Jun; 42(3):205-13. PubMed ID: 9381263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.